Muhammad Aron Pase. (2024). Tirzepatide: Dual GIP/GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity. ‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes, 1(2), 96-110. https://doi.org/10.66266/inajemd.v1i2.23